Plasma selenium and the risk of first stroke in adults with hypertension: a secondary analysis of the China Stroke Primary Prevention Trial.
Zhuo WangHai MaYun SongTengfei LinLishun LiuZiyi ZhouYa-Ping WeiXiao HuangPing ChenChengzhang LiuYoubao LiBinyan WangJianping LiYan ZhangYong HuoHao ZhangXiping XuXianhui QinHuiyuan GuoPublished in: The American journal of clinical nutrition (2021)
In summary, there was a significant inverse association between plasma Se and risk of first stroke in Chinese adults with hypertension, especially among those with higher baseline folate concentrations and those with higher time-averaged SBP over the treatment period.Trial registration number: NCT00794885URL of registration: https://www.clinicaltrials.gov/ct2/show/NCT00794885?term=NCT00794885&draw=2&r.